BioSpace News Archive

Successful first half: Order intake1 up 27.5 percent, Group sales revenue up 17.9 percent, underlying EBITDA1 margin reaches 27.8 percent

Araim Pharmaceuticals Inc., announced the publication of results from an exploratory clinical trial indicating efficacy of their lead compound, cibinetide, in treatment of diabetic macular edema .

Midatech Pharma’s next generation drug delivery technologies to be applied to new modalities in collaboration with a European pharmaceutical company.

Tubulis announced the close of a €10.7 million Series A financing round to accelerate the development of a new class of highly stable and efficient antibody-drug conjugates and to support the further growth of the company.

More than 100,000 Life Sciences Researchers, Clinicians and Professionals in 84 Countries Utilizing Innovative SaaS Solution to Help Speed New Drug Therapies to Market

Montefiore Health System becomes the 39th member of the Caris collaborative network focused on expanding the application of precision medicine in oncology

Lexicon Pharmaceuticals, Inc., announced topline data from four Phase 3 sotagliflozin studies in type 2 diabetes: SOTA-MONO, SOTA-SU, SOTA-GLIM and SOTA-INS.

BD, a leading global medical technology company, announced additional pandemic orders for needles and syringes from the United States and Canada totaling 177 million injection devices.

RedHill Biopharma Ltd., a specialty biopharmaceutical company, announced it is seeking regulatory review by the Securities and Exchange Commission, and intends to approach the Financial Industry Regulatory Authority, Inc., regarding suspicious trading activity including potential naked short selling of the Company’s stock.

Inspired Spine Introducing New Technology to Revolutionize SI Joint Disease Treatment. “We continue to raise the standard of care for back pain treatment as this SI Joint fusion technique represents another Inspired Spine breakthrough for surgeons and patients alike,” stated Inspired Spine CMO Dr. Hamid Abbasi.